Cells (Dec 2022)

Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor

  • Linda Jansen-Olliges,
  • Shambhabi Chatterjee,
  • Lili Jia,
  • Frank Stahl,
  • Christian Bär,
  • Marc Stadler,
  • Frank Surup,
  • Carsten Zeilinger

DOI
https://doi.org/10.3390/cells12010083
Journal volume & issue
Vol. 12, no. 1
p. 83

Abstract

Read online

Protein microarray screenings identified fungal natural products from the azaphilone family as potent inhibitors of SARS-CoV-2 spike protein binding to host ACE2 receptors. Cohaerin F, as the most potent substance from the cohaerin group, led to more than 50% less binding of ACE2 and SARS-CoV-2 spike protein. A survey for structurally related azaphilones yielded the structure elucidation of six new multiformins E–J (10–15) and the revision of the stereochemistry of the multiformins. Cohaerin and multiformin azaphilones (1–5, 8, 12) were assessed for their activity in a cell-based infection assay. Calu-3 cells expressing human ACE2 receptor showed more than 75% and 50% less infection by SARS-CoV-2 pseudotyped lentivirus particles after treatment with cohaerin C (1) and cohaerin F (4), respectively. Multiformin C (8) and G (12) that nearly abolished the infection of cells. Our data show that multiformin-type azaphilones prevent the binding of SARS-CoV-2 to the cell entry receptor ACE2.

Keywords